Overview Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects Status: Not yet recruiting Trial end date: 2022-11-22 Target enrollment: Participant gender: Summary Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical